Article Details

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi ...

Retrieved on: 2023-10-28 16:14:08

Tags for this article:

Click the tags to see associated articles and topics

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi .... View article details on hiswai:

Excerpt

LOQTORZI is the first and only FDA-approved treatment for NPC –. – Indicated in combination with chemotherapy for 1st line treatment and as ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up